| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/24/2023 | Fasman Steven L | EVP & Chief Admin Officer | Sale | Common Stock | 817 | $44.65 | $36.5k | | 08/23/2023 |
| 08/24/2023 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Sale | Common Stock | 396 | $44.49 | $17.6k | | 08/23/2023 |
| 08/24/2023 | Maselli Alessandro | President & CEO | Sale | Common Stock | 2k | $44.51 | $87.7k | | 08/23/2023 |
| 08/24/2023 | Maselli Alessandro | President & CEO | Sale | Common Stock | 101 | $45.15 | $4.6k | | 08/23/2023 |
| 08/24/2023 | Gunther Scott | SVP, Quality & Reg. Affairs | Sale | Common Stock | 269 | $44.57 | $12k | | 08/23/2023 |
| 08/24/2023 | Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | Sale | Common Stock | 87 | $44.87 | $3.9k | | 08/23/2023 |
| 08/24/2023 | Pravda Ricardo | Chief Transformation Officer | Sale | Common Stock | 379 | $44.47 | $16.9k | | 08/23/2023 |
| 08/24/2023 | Grippo Michael J | SVP, Strategy & Corp. Dev. | Sale | Common Stock | 390 | $44.50 | $17.4k | | 08/23/2023 |
| 08/24/2023 | Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | Sale | Common Stock | 216 | $44.71 | $9.7k | | 08/23/2023 |
| 08/24/2023 | Hopson Ricky | Pres. Clinical Dev Supply Div | Sale | Common Stock | 276 | $44.56 | $12.3k | | 08/23/2023 |
| 08/24/2023 | Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | Sale | Common Stock | 147 | $44.72 | $6.6k | | 08/23/2023 |
| 08/24/2023 | Lickfold Charles | SVP, CIO | Sale | Common Stock | 190 | $44.72 | $8.5k | | 08/23/2023 |
| 08/24/2023 | Hunt Patricia | Pres. Consumer Health Div | Sale | Common Stock | 106 | $44.77 | $4.7k | | 08/23/2023 |
| 08/23/2023 | Lickfold Charles | SVP, CIO | Grant | Common Stock | 637 | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Hunt Patricia | Pres. Consumer Health Div | Grant | Common Stock | 289 | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Hawkeswood Thomas W | Pres. Pharma Prod Delivery Div | Grant | Common Stock | 268 | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Carletti Lorenzo | SVP Global Ops Ph & Cons Hlth | Grant | Common Stock | 457 | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Hopson Ricky | Pres. Clinical Dev Supply Div | Grant | Common Stock | 789 | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Grippo Michael J | SVP, Strategy & Corp. Dev. | Grant | Common Stock | 1.1k | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Pravda Ricardo | Chief Transformation Officer | Grant | Common Stock | 1.1k | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Gunther Scott | SVP, Quality & Reg. Affairs | Grant | Common Stock | 1.1k | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Arnold Jonathan | SVP, CCO & Div. Head BioP Del. | Grant | Common Stock | 1.6k | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Maselli Alessandro | President & CEO | Grant | Common Stock | 4k | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Grant | Common Stock | 1.6k | $0.00 | $0 | | 08/23/2023 |
| 08/23/2023 | Fasman Steven L | EVP & Chief Admin Officer | Grant | Common Stock | 2.2k | $0.00 | $0 | | 08/23/2023 |
| 08/01/2023 | Fasman Steven L | EVP & Chief Admin Officer | Sale | Common Stock | 1.1k | $46.72 | $52k | | 08/01/2023 |
| 08/01/2023 | Fasman Steven L | EVP & Chief Admin Officer | Sale | Common Stock | 524 | $47.76 | $25k | | 08/01/2023 |
| 08/01/2023 | Fasman Steven L | EVP & Chief Admin Officer | Grant | Common Stock | 11.9k | $0.00 | $0 | | 08/01/2023 |
| 08/01/2023 | Fasman Steven L | EVP & Chief Admin Officer | Grant | Options to purchase Common Stock | 26.5k | $46.51 | $1.2M | | 08/01/2023 |
| 08/01/2023 | Zayas Ricardo | SVP, Operations, Biologics NA | Grant | Common Stock | 4.4k | $0.00 | $0 | | 08/01/2023 |
| 08/01/2023 | Zayas Ricardo | SVP, Operations, Biologics NA | Grant | Options to purchase Common Stock | 9.9k | $46.51 | $459.4k | | 08/01/2023 |
| 08/01/2023 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Sale | Common Stock | 61 | $46.58 | $2.8k | | 08/01/2023 |
| 08/01/2023 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Sale | Common Stock | 220 | $47.87 | $10.5k | | 08/01/2023 |
| 08/01/2023 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Grant | Common Stock | 8.9k | $0.00 | $0 | | 08/01/2023 |
| 08/01/2023 | Gennadios Aristippos | Group Pres. Pharma & Consumer | Grant | Options to purchase Common Stock | 19.8k | $46.51 | $918.9k | | 08/01/2023 |
|